Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201401078 Principal Investigator: Adkins, Douglas
Title: A phase Ib dose escalation/randomized phase II, multicenter, open-label study of BYL719 in combination with cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma
Phase: I Disease Site: Lip, Oral Cavity and Pharynx
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find out if the combination treatment of cetuximab and BYL719 is safe and has a beneficial effect in patients with head and neck cancer.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)